Resection prior to liver transplantation for hepatocellular carcinoma

被引:339
作者
Beighiti, J
Cortes, A
Abdalla, EK
Régimbeau, JM
Prakash, K
Durand, F
Sommacale, D
Dondero, F
Lesurtel, M
Sauvanet, A
Farges, O
Kianmanesh, R
机构
[1] Univ Paris 07, Dept HepatoPancreatoBiliary Surg & Transplantat, Hosp Beaujon, Clichy, France
[2] Univ Paris 07, Dept Hepatol & Transplantat, Hosp Beaujon, Clichy, France
关键词
D O I
10.1097/01.sla.0000098621.74851.65
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: To evaluate the feasibility and postoperative course of liver transplantation (LT) in cirrhotic patients who underwent liver resection prior to LT for HCC. Summary Background Data: Although LT provides longer survival than liver resection for treatment of small HCCs, donor shortage and long LT wait time may argue against LT. The feasibility and survival following LT after hepatic resection have not been previously examined. Methods: Between 1991 and 2001, among 107 patients who underwent LT for HCC, 88 met Mazzafero's criteria upon pathologic analysis of the explant. Of these, 70 underwent primary liver transplantation (PLT) and 18 liver resection prior to secondary liver transplantation (SLT) for recurrence (n = 11), deterioration of liver function (n = 4), or high risk for recurrence (n = 3). Perioperative and postoperative factors and long-term survival were compared. Results: Comparison of PLT and SLT groups at the time of LT revealed similar median age (53 vs. 55 years), sex, and etiology of liver disease (alcohol/viral B/C/other). In the SLT group, the mean time between liver resection and listing for LT was 20 months (range 1-84 months). Overall time on LT waiting list of the two groups was similar (3 vs. 5 months). Pathologic analysis after LT revealed similar tumor size (2.2 vs. 2.3 cm) and number (1.6 vs. 1.7). Perioperative and postoperative courses were not different in terms of operative time (551 vs. 530 minutes), blood loss (1191 vs. 1282 mL), transfusion (3 vs. 2 units), ICU (9 vs. 10 days) or hospital stay (32 vs. 31 days), morbidity (51% vs. 56%) or 30-day mortality (5.7% vs. 5.6%). During a median follow-up of 32 months (3 to 158 months), 3 patients recurred after PLT and one after SLT. After transplantation, 3- and 5-year overall survivals were not different between groups (82 vs. 82% and 59 vs. 61%). Conclusions: In selected patients, liver resection prior to transplantation does not increase the morbidity or impair long-term survival following LT. Therefore, liver resection prior to transplantation can be integrated in the treatment strategy for HCC.
引用
收藏
页码:885 / 892
页数:8
相关论文
共 41 条
[1]   Decision for retransplantation of the liver - An experience- and cost-based analysis [J].
Azoulay, D ;
Linhares, MM ;
Huguet, E ;
Delvart, V ;
Castaing, D ;
Adam, R ;
Ichai, P ;
Saliba, F ;
Lemoine, A ;
Samuel, D ;
Bismuth, H .
ANNALS OF SURGERY, 2002, 236 (06) :713-721
[2]   Feasibility and limits of caval-flow preservation during liver transplantation [J].
Belghiti, J ;
Ettorre, GM ;
Durand, F ;
Sommacale, D ;
Sauvanet, A ;
Jerius, JT ;
Farges, O .
LIVER TRANSPLANTATION, 2001, 7 (11) :983-987
[3]   TEMPORARY PORTACAVAL ANASTOMOSIS WITH PRESERVATION OF CAVAL FLOW DURING ORTHOTOPIC LIVER-TRANSPLANTATION [J].
BELGHITI, J ;
NOUN, R ;
SAUVANET, A .
AMERICAN JOURNAL OF SURGERY, 1995, 169 (02) :277-279
[4]   LIVER RESECTION VERSUS TRANSPLANTATION FOR HEPATOCELLULAR-CARCINOMA IN CIRRHOTIC-PATIENTS [J].
BISMUTH, H ;
CHICHE, L ;
ADAM, R ;
CASTAING, D ;
DIAMOND, T ;
DENNISON, A .
ANNALS OF SURGERY, 1993, 218 (02) :145-151
[5]   Is hepatocellular carcinoma in cirrhosis an actual indication for liver transplantation? [J].
Colella, G ;
DeCarlis, L ;
Rondinara, GF ;
Sansalone, CV ;
Belli, LS ;
Aseni, P ;
Slim, AI ;
Gelosa, F ;
Iamoni, GM ;
Corti, A ;
Mazza, E ;
Arcieri, K ;
Giacomoni, A ;
Minola, E ;
Ideo, G ;
Forti, D .
TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) :492-494
[6]  
Dmitrewski J, 1998, J Hepatobiliary Pancreat Surg, V5, P18, DOI 10.1007/PL00009945
[7]  
Durand F, 2002, HEPATO-GASTROENTEROL, V49, P47
[8]   Rising incidence of hepatocellular carcinoma in the United States [J].
El-Serag, HB ;
Mason, AC .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (10) :745-750
[9]   Safety of donors in live donor liver transplantation using right lobe grafts [J].
Fan, ST ;
Lo, CM ;
Liu, CL ;
Yong, BH ;
Chan, JKF ;
Ng, IOL .
ARCHIVES OF SURGERY, 2000, 135 (03) :336-340
[10]   Technical refinement in adult-to-adult living donor liver transplantation using right lobe graft [J].
Fan, ST ;
Lo, CM ;
Liu, CL .
ANNALS OF SURGERY, 2000, 231 (01) :126-131